Armata PharmaceuticalsARMP
13F holders, Q4 2024 (December 31)24holders
1new positions
2sold out
1famous investor
$1.85avg. 13F price*
At the end of Q4 2024, 24 institutions reported holding Armata Pharmaceuticals Inc. (ARMP) in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 2 sold out. The largest holders were Bank of America Corp. ($1.2M), Vanguard Group Inc. ($433K) and Geode Capital Management, LLC ($198K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Armata Pharmaceuticals Inc.
- CUSIP
- 04216R102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $132 |
| Exits | 2 | $18K |
All 13F filers, Q3 2024 → Q4 2024: 34,168 shares bought and 29,012 shares sold, net +5,156 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Bank of America Corp. | 0.00% | Reduce 0.0% | 634,032 | $1.2M |
| Vanguard Group Inc. | 0.00% | Add +3.9% | 234,119 | $433K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.3% | 106,789 | $198K |
| Edgewood Management LLC | 0.00% | No change | 100,000 | $185K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -7.6% | 69,682 | $129K |
| Susquehanna International Group, LLP | 0.00% | Add +67.2% | 49,788 | $92K |
| State Street Corp. | 0.00% | No change | 40,300 | $75K |
| Renaissance Technologies | 0.00% | Reduce -13.3% | 40,291 | $75K |
| SeaCrest Wealth Management, LLC | 0.01% | No change | 34,954 | $65K |
| BlackRock, Inc. | 0.00% | Reduce -0.8% | 23,625 | $44K |
| Northern Trust Corp. | 0.00% | No change | 19,273 | $36K |
| Captrust Financial Advisors | 0.00% | No change | 13,140 | $24K |
| Group One Trading LLC | 0.00% | Reduce -42.8% | 11,614 | $21K |
| UBS Group AG | 0.00% | Add +167.8% | 6,313 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +65.2% | 3,312 | $6K |
| Cornerstone National Bank & Trust Co | 0.00% | No change | 1,428 | $3K |
| Trifecta Capital Advisors, LLC | 0.00% | No change | 714 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 571 | $1K |
| Morgan Stanley | 0.00% | No change | 109 | $202 |
| Salem Investment Counselors Inc. | 0.00% | No change | 100 | $185 |
| MAI Capital Management | 0.00% | New | 71 | $132 |
| JPMorgan Chase & Co. | 0.00% | Reduce -3.9% | 25 | $46 |
| SBI Securities Co., Ltd. | 0.00% | — | 3 | $6 |
| Wells Fargo & Company | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is ARMP's weight in each manager's 13F, not the share of Armata Pharmaceuticals Inc. the manager owns.